The future of vaccines for tuberculosis
Exciting clinical results from 2 clinical TB vaccine trials were published in 2018. These, plus promising preclinical candidates form a healthy pipeline of potential vaccines against the leading cause of death from a single infectious agent. The only licensed vaccine, the BCG, continues to be an imp...
| Main Authors: | , |
|---|---|
| Format: | Journal article |
| Published: |
Elsevier
2019
|